Latest Articles
Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer - Targeted Oncology
Frontline Strategy: Why You Must Use IO Upfront in Endometrial Cancer Targeted Oncology
Published: Oct. 22, 2025, 6:21 p.m.
Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial - Targeted Oncology
Endometrial Cancer: Dostarlimab/Chemo Improves OS in Frontline RUBY Trial Targeted Oncology
Published: Oct. 22, 2025, 5:11 p.m.
Association of white blood cell count to hemoglobin ratio with the life quality after laparoscopic surgery in patients with endometriosis.
Endometriosis (EM) is a common hormone-dependent and chronic inflammatory disease affecting women of reproductive age, characterized by pelvic pain, infertility, and reduced quality of life. Laparoscopic surgery is a primary …
Published: Oct. 13, 2025, midnight
Two Cases of Mesonephric-Like Adenocarcinoma Arising From Ovary and Peritoneal and Literature Review.
Reports of Mesonephric-like adenocarcinoma (MLA) arising from other than the ovary and uterus are exceedingly rare. This report details two cases of MLA in patients with a history of endometriosis. …
Published: Oct. 12, 2025, midnight
Poll Results Highlight Gynecologic Oncology Abstracts to Watch Ahead of ESMO 2025 - OncLive
Poll Results Highlight Gynecologic Oncology Abstracts to Watch Ahead of ESMO 2025 OncLive
Published: Oct. 10, 2025, 12:07 p.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - BioSpace
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 BioSpace
Published: Oct. 3, 2025, 10:53 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - JCN Newswire
Eisai Highlights Breadth of Oncology Research at ESMO 2025 JCN Newswire
Published: Oct. 3, 2025, 9:01 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - ACN Newswire - ACN Newswire
Eisai Highlights Breadth of Oncology Research at ESMO 2025 - ACN Newswire ACN Newswire
Published: Oct. 3, 2025, 9:01 a.m.
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 - Morningstar
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775 Morningstar
Published: Oct. 2, 2025, 12:08 p.m.
UC Cancer Center members present radiation oncology research at national conference - University of Cincinnati
UC Cancer Center members present radiation oncology research at national conference University of Cincinnati
Published: Sept. 29, 2025, 2:39 p.m.
Link copied to clipboard!